CIZZLE BIOTECHN. LS-0001
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings … Read more
Market Cap & Net Worth: CIZZLE BIOTECHN. LS-0001 (E7F0)
CIZZLE BIOTECHN. LS-0001 (F:E7F0) has a market capitalization of $7.53 Million (€7.33 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #31059 globally and #3445 in its home market, demonstrating a 23.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CIZZLE BIOTECHN. LS-0001's stock price €0.02 by its total outstanding shares 396391773 (396.39 Million).
CIZZLE BIOTECHN. LS-0001 Market Cap History: 2021 to 2026
CIZZLE BIOTECHN. LS-0001's market capitalization history from 2021 to 2026. Data shows change from $18.31 Million to $7.53 Million (-22.91% CAGR).
CIZZLE BIOTECHN. LS-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CIZZLE BIOTECHN. LS-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of E7F0 by Market Capitalization
Companies near CIZZLE BIOTECHN. LS-0001 in the global market cap rankings as of March 19, 2026.
Key companies related to CIZZLE BIOTECHN. LS-0001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CIZZLE BIOTECHN. LS-0001 Historical Marketcap From 2021 to 2026
Between 2021 and today, CIZZLE BIOTECHN. LS-0001's market cap moved from $18.31 Million to $ 7.53 Million, with a yearly change of -22.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €7.53 Million | +23.33% |
| 2025 | €6.10 Million | -23.08% |
| 2024 | €7.93 Million | -11.36% |
| 2023 | €8.95 Million | +37.50% |
| 2022 | €6.51 Million | -64.44% |
| 2021 | €18.31 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of CIZZLE BIOTECHN. LS-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.53 Million USD |
| MoneyControl | $7.53 Million USD |
| MarketWatch | $7.53 Million USD |
| marketcap.company | $7.53 Million USD |
| Reuters | $7.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.